-+ 0.00%
-+ 0.00%
-+ 0.00%

Three Days Left To Buy Vistin Pharma ASA (OB:VISTN) Before The Ex-Dividend Date

Simply Wall St·11/20/2026 04:31:49
Listen to the news

Readers hoping to buy Vistin Pharma ASA (OB:VISTN) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. Typically, the ex-dividend date is two business days before the record date, which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is of consequence because whenever a stock is bought or sold, the trade can take two business days or more to settle. In other words, investors can purchase Vistin Pharma's shares before the 24th of November in order to be eligible for the dividend, which will be paid on the 27th of November.

The company's next dividend payment will be kr00.50 per share, on the back of last year when the company paid a total of kr1.50 to shareholders. Last year's total dividend payments show that Vistin Pharma has a trailing yield of 7.7% on the current share price of kr019.50. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. So we need to check whether the dividend payments are covered, and if earnings are growing.

Dividends are usually paid out of company profits, so if a company pays out more than it earned then its dividend is usually at greater risk of being cut. Last year Vistin Pharma paid out 106% of its profits as dividends to shareholders, suggesting the dividend is not well covered by earnings. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. It paid out more than half (52%) of its free cash flow in the past year, which is within an average range for most companies.

It's disappointing to see that the dividend was not covered by profits, but cash is more important from a dividend sustainability perspective, and Vistin Pharma fortunately did generate enough cash to fund its dividend. Still, if the company repeatedly paid a dividend greater than its profits, we'd be concerned. Extraordinarily few companies are capable of persistently paying a dividend that is greater than their profits.

See our latest analysis for Vistin Pharma

Click here to see how much of its profit Vistin Pharma paid out over the last 12 months.

historic-dividend
OB:VISTN Historic Dividend November 20th 2026

Have Earnings And Dividends Been Growing?

Companies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. It's encouraging to see Vistin Pharma has grown its earnings rapidly, up 39% a year for the past five years.

The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Vistin Pharma has delivered an average of 9.6% per year annual increase in its dividend, based on the past 10 years of dividend payments. We're glad to see dividends rising alongside earnings over a number of years, which may be a sign the company intends to share the growth with shareholders.

To Sum It Up

From a dividend perspective, should investors buy or avoid Vistin Pharma? Growing earnings per share and a normal cashflow payout ratio is an ok combination, but we're concerned that the company is paying out such a high percentage of its income as dividends. In summary, while it has some positive characteristics, we're not inclined to race out and buy Vistin Pharma today.

If you're not too concerned about Vistin Pharma's ability to pay dividends, you should still be mindful of some of the other risks that this business faces. Every company has risks, and we've spotted 2 warning signs for Vistin Pharma you should know about.

A common investing mistake is buying the first interesting stock you see. Here you can find a full list of high-yield dividend stocks.